Purchase Order 75N91023P00625
Award Date 7/20/23
Potential Completion Date 7/19/24
Potential Value $14K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Minneapolis, MN 55413, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $19,382.50 firm fixed price purchase order to Bio-Techne Sales Corporation of Minneapolis, Minnesota. The order is for ELISPOT KITS to be delivered between August 21, 2023 and September 20, 2023. The National Cancer Institute conducts and supports research into the causes, prevention, diagnosis, and treatment of cancer through its various programs and divisions. No set aside...
- <p>The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a $25,000 purchase order to Bio-Techne Sales Corporation of Minneapolis, Minnesota. This firm fixed price contract runs from September 2022 through September 2023 and will provide unspecified products or services to support NIH Clinical Center programs. Bio-Techne will perform all work as the prime contractor. No subcontractors or additional context were provided regarding the award.</p>
- The U.S. National Institutes of Health (NIH) Clinical Center awarded a $24,461.93 firm fixed price purchase order to Bio-Techne Sales Corporation, a for-profit provider of biological research products. The contract is for the delivery of Bio-Techne kits and materials, which are used to support various scientific and medical research programs at the NIH, including studies related to cancer, environmental health, substance abuse, and translational science. The period of performance runs through...
- This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, to Bio-Techne Sales Corporation, a for-profit organization specializing in biological research products and materials. The $12,757.50 contract is for the delivery of fetal bovine serum, a critical research material used in various medical and scientific research programs. The award has no...
- The National Cancer Institute awarded a $24.9K firm fixed-price contract to Research and Diagnostic Systems, Inc. (R&D Systems) on May 25, 2021, for the purchase of eighty-three 500 ml bottles of fetal bovine serum, Lot #K19150. This contract was executed as a call against an existing Blanket Purchase Agreement and represents a non-competitive procurement. The place of performance is Minneapolis, Minnesota, where R&D Systems maintains its headquarters as a subsidiary of Bio-Techne...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $19,961.98 purchase order to Cell Culture Collective, Inc. for fetal bovine serum. Cell Culture Collective, Inc. will deliver the requested serum to support biomedical research efforts under this firm fixed price contract. Performance will take place in Encinitas, California over a one-month period concluding in late September 2023. No set aside designation or subcontractors were...
- The National Cancer Institute awarded a $14,976 firm fixed-price Blanket Purchase Agreement (BPA) call to Research and Diagnostic Systems, Inc. (R&D Systems) on August 18, 2021, for the supply of Fetal Bovine Serum – Optima, with performance completion by September 30, 2021. The award was made through open competition with no set-aside designation. R&D Systems, a Minneapolis-based manufacturer of biological research materials and subsidiary of Bio-Techne Corporation, specializes in...
- The National Cancer Institute awarded a Blanket Purchase Agreement (BPA) call to Atlanta Biologicals, Inc., a subsidiary of Bio-Techne Corporation, for the supply of Fetal Bovine Serum (FBS) Optima under Quote #51139. This firm fixed-price contract, with a ceiling value of $8,857.30, was executed on June 27, 2018, with an ultimate completion date of July 26, 2018. The contract was fulfilled at the vendor's facility in Flowery Branch, Georgia, and was not designated as a set-aside contract. Fetal...
- This federal contract award from the Department of Health and Human Services' National Institutes of Health's National Cancer Institute is for laboratory supplies with a potential value of fourteen thousand four hundred seventy-eight dollars and fifty-two cents ($14,478.52). Life Technologies Corporation of Billerica, Massachusetts has been awarded a firm fixed price call against a blanket purchase agreement to deliver the requested lab supplies by January 31, 2024 in support of the National...
- The National Cancer Institute awarded a $16,250 firm fixed price Blanket Purchase Agreement (BPA) call to Research and Diagnostic Systems, Inc. (R&D Systems) on May 5, 2021, for fetal bovine serum premium in 500 mL quantities. The contract, which was completed by May 27, 2021, was performed in Minneapolis, Minnesota, where R&D Systems is headquartered. No set-aside designation was used for this procurement, indicating open competition. R&D Systems, a subsidiary of Bio-Techne...